Drug Pipeline Progress: Positive clinical trial results for PTTN's drug candidates can drive the stock price up, while failures can cause it to fall.

Regulatory Approvals: FDA approvals for PTTN's drugs are major catalysts, leading to price increases. Rejections or delays can negatively impact the stock.

Market Sentiment: Overall investor confidence in the biotechnology sector and PTTN specifically can influence buying and selling pressure.

Competition: The presence and success of competing drugs in the market can impact the potential market share and revenue for PTTN's products, affecting its stock price.

Financial Performance: PTTN's revenue, profitability, and cash flow influence investor perception of its financial health and future prospects.

Partnerships and Acquisitions: Strategic collaborations or acquisitions can boost investor confidence and increase the stock price.

Macroeconomic Factors: Economic downturns or changes in interest rates can affect the overall stock market and impact PTTN's stock price.

Patent Protection: Strong patent protection for PTTN's drugs is crucial for maintaining market exclusivity and can positively influence the stock price.